Reduced isolation-induced pup ultrasonic communication in mouse pups lacking brain serotonin

Molecular Autism

Volumn 6, Issue 1, 2015, Pages

  Mosienko, Valentina ^a,b   Beis, Daniel ^a   Alenina, Natalia ^a,c   Wöhr, Markus ^d  

^a MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c ST PETERSBURG STATE UNIVERSITY   (Russian Federation)

^d PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Animal models; Autism; Communication; Neurodevelopmental disorders; Serotonin; Ultrasonic vocalizations

Indexed keywords

SEROTONIN; TRYPTOPHAN HYDROXYLASE 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; EXPERIMENTAL SOCIAL BEHAVIOR TEST; FEMALE; GENOTYPE; GROWTH RETARDATION; INTERPERSONAL COMMUNICATION; ISOLATION INDUCED PUP ULTRASONIC COMMUNICATION; MALE; MOUSE; NONHUMAN; PRENATAL DEVELOPMENT; PRIORITY JOURNAL; PUP (RODENT); THERMOREGULATION; VOCALIZATION;

ANIMALIA; MAMMALIA; MUS; RODENTIA;

EID: 84928012732     PISSN: None     EISSN: 20402392     Source Type: Journal    
DOI: 10.1186/s13229-015-0003-6     Document Type: Article

References (89)

1. Descarries L, Riad M, Parent M. Ultrastructure of the serotonin innervation in the mammalian nervous system. In: Müller CP, Jacobs BL, editors. Handbook of the behavioral neurobiology of serotonin. Amsterdam: Academic Press; 2010. p. 65-101.
2. Gaspar P, Cases O, Maroteaux L. The developmental role of serotonin: news from mouse molecular genetics. Nat Rev Neurosci. 2003;4:1002-10012.
3. Whitaker-Azmitia PM. Serotonin and development. In: Müller CP, Jacobs BL, editors. Handbook of the behavioral neurobiology of serotonin. Amsterdam: Academic Press; 2010. p. 309-23.
4. Hohmann CF, Blue ME. The role of serotonin in cortical development: implications for autism spectrum disorders. In: Müller CP, Jacobs BL, editors. Handbook of the behavioral neurobiology of serotonin. Amsterdam: Academic Press; 2010. p. 637-65.
5. Diagnostic and Statistical Manual of Mental Disorders, 5th edn. American Psychiatric Publishing, Arlington, VA, USA; 2013
6. Silverman JL, Yang M, Lord C, Crawley JN. Behavioural phenotyping assays for mouse models of autism. Nat Rev Neurosci. 2010;11:490-502.
7. Wöhr M, Scattoni ML. Behavioural methods used in rodent models of autism spectrum disorders: current standards and new developments. Behav Brain Res. 2013;251:5-17.
8. Michetti C, Ricceri L, Scattoni ML. Modeling social communication deficits in mouse models of autism. Autism. 2012;S1:007.
9. Scattoni ML, Crawley J, Ricceri L. Ultrasonic vocalizations: a tool for behavioural phenotyping of mouse models of neurodevelopmental disorders. Neurosci Biobehav Rev. 2009;33:508-15.
10. Wöhr M. Ultrasonic vocalizations in Shank mouse models for autism spectrum disorders: detailed spectrographic analyses and developmental profiles. Neurosci Biobehav Rev. 2014;43:199-212.
11. Hård E, Engel J, Musi B. The ontogeny of defensive reactions in the rat: influence of the monoamine transmission systems. Scand J Psychol. 1982;S1:90-6.
12. Winslow JT, Insel TR. Serotonergic modulation of rat pup ultrasonic vocal development: studies with 3,4-methylenedioxymethamphetamine. J Pharmacol Exp Ther. 1990;254:212-20.
13. Richardson-Jones JW, Craige CP, Nguyen TH, Kung HF, Gardier AM, Dranovsky A, et al. Serotonin-1A autoreceptors are necessary and sufficient for the normal formation of circuits underlying innate anxiety. J Neurosci. 2011;31:6008-18.
14. Fish EW, Sekinda M, Ferrari PF, Dirks A, Miczek KA. Distress vocalizations in maternally separated mouse pups: modulation via 5-HT(1A), 5-HT(1B) and GABA(A) receptors. Psychopharmacology (Berl). 2000;149:277-85.
15. Nastiti K, Benton D, Brain PF, Haug M. The effects of 5-HT receptor ligands on ultrasonic calling in mouse pups. Neurosci Biobehav Rev. 1991;15:483-7.
16. Hård E, Engel J. Effects of 8-OH-DPAT on ultrasonic vocalization and audiogenic immobility reaction in pre-weanling rats. Neuropharmacology. 1988;27:981-6.
17. Johansson-Wallsten CE, Berg M, Meyerson BJ. The effects of long-term treatment with the 5-HT1A receptor agonist 8-OH-DPAT and the 5-HT2/1C receptor agonist DOI in the neonatal rat. Eur J Pharmacol. 1993;243:149-54.
18. Joyce MP, Carden SE. The effects of 8-OH-DPAT and (+/-)-pindolol on isolation-induced ultrasonic vocalizations in 3-, 10-, and 14-day-old rats. Dev Psychobiol. 1999;34:109-17.
19. Klint T, Andersson G. Ultrasound vocalization is not related to corticosterone response in isolated rat pups. Pharmacol Biochem Behav. 1994;47:947-50.
20. Mos J, Olivier B. Ultrasonic vocalizations by rat pups as an animal model for anxiolytic activity: effects of serotonergic drugs. In: Bevan P, Cools AR, Archer T, editors. Behavioural Pharmacology of 5-HT. Hillsdale: Lawrence Erlbaum; 1989. p. 361-6.
21. Olivier B, Molewijk HE, van der Heyden JA, van Oorschot R, Ronken E, Mos J, et al. Ultrasonic vocalizations in rat pups: effects of serotonergic ligands. Neurosci Biobehav Rev. 1998;23:215-27.
22. Shayit M, Yadid G, Overstreet DH, Weller A. 5-HT(1A) receptor subsensitivity in infancy and supersensitivity in adulthood in an animal model of depression. Brain Res. 2003;980:100-8.
23. Winslow JT, Insel TR. Serotonergic modulation of the rat pup ultrasonic isolation call: studies with 5HT1 and 5HT2 subtype-selective agonists and antagonists. Psychopharmacology (Berl). 1991;105:513-20.
24. Fish EW, Faccidomo S, Gupta S, Miczek KA. Anxiolytic-like effects of escitalopram, citalopram, and R-citalopram in maternally separated mouse pups. J Pharmacol Exp Ther. 2004;308:474-80.
25. Hodgson RA, Guthrie DH, Varty GB. Duration of ultrasonic vocalizations in the isolated rat pup as a behavioral measure: sensitivity to anxiolytic and antidepressant drugs. Pharmacol Biochem Behav. 2008;88:341-8.
26. Iijima M, Chaki S. Separation-induced ultrasonic vocalization in rat pups: further pharmacological characterization. Pharmacol Biochem Behav. 2005;82:652-7.
27. Kehne JH, Coverdale S, McCloskey TC, Hoffman DC, Cassella JV. Effects of the CRF(1) receptor antagonist, CP 154,526, in the separation-induced vocalization anxiolytic test in rat pups. Neuropharmacology. 2000;39:1357-67.
28. Starr KR, Price GW, Watson JM, Atkinson PJ, Arban R, Melotto S, et al. SB-649915-B, a novel 5-HT1A/B autoreceptor antagonist and serotonin reuptake inhibitor, is anxiolytic and displays fast onset activity in the rat high light social interaction test. Neuropsychopharmacology. 2007;32:2163-72.
29. Winslow JT, Insel TR. Serotonergic and catecholaminergic reuptake inhibitors have opposite effects on the ultrasonic isolation calls of rat pups. Neuropsychopharmacology. 1990;3:51-9.
30. Walther DJ, Peter JU, Bashammakh S, Hörtnagl H, Voits M, Fink H, et al. Synthesis of serotonin by a second tryptophan hydroxylase isoform. Science. 2003;299:76.
31. Alenina N, Kikic D, Todiras M, Mosienko V, Qadri F, Plehm R, et al. Growth retardation and altered autonomic control in mice lacking brain serotonin. Proc Natl Acad Sci U S A. 2009;106:10332-7.
32. Gutknecht L, Araragi N, Merker S, Waider J, Sommerlandt FM, Mlinar B, et al. Impacts of brain serotonin deficiency following Tph2 inactivation on development and raphe neuron serotonergic specification. PLoS One. 2012;7:e43157.
33. Kane MJ, Angoa-Peréz M, Briggs DI, Sykes CE, Francescutti DM, Rosenberg DR, et al. Mice genetically depleted of brain serotonin display social impairments, communication deficits and repetitive behaviors: possible relevance to autism. PLoS One. 2012;7:e48975.
34. Migliarini S, Pacini G, Pelosi B, Lunardi G, Pasqualetti M. Lack of brain serotonin affects postnatal development and serotonergic neuronal circuitry formation. Mol Psychiatry. 2013;18:1106-18.
35. Narboux-Nême N, Angenard G, Mosienko V, Klempin F, Pitychoutis PM, Deneris E, et al. Postnatal growth defects in mice with constitutive depletion of central serotonin. ACS Chem Neurosci. 2013;4:171-81.
36. Angoa-Pérez M, Kane MJ, Briggs DI, Sykes CE, Shah MM, Francescutti DM, et al. Genetic depletion of brain 5HT reveals a common molecular pathway mediating compulsivity and impulsivity. J Neurochem. 2012;121:974-84.
37. Mosienko V, Bert B, Beis D, Matthes S, Fink H, Bader M, et al. Exaggerated aggression and decreased anxiety in mice deficient in brain serotonin. Transl Psychiatry. 2012;2:e122.
38. Angoa-Pérez M, Kane MJ, Sykes CE, Perrine SA, Church MW, Kuhn DM. Brain serotonin determines maternal behavior and offspring survival. Genes Brain Behav. 2014;13:579-91.
39. Mosienko V, Beis D, Pasqualetti M, Waider J, Matthes S, Qadri F, et al. Life without brain serotonin: reevaluation of serotonin function with mice deficient in brain serotonin synthesis. Behav Brain Res. 2014. doi: 10.1016/j.bbr.2014.06.005.
40. Liu Y, Jiang Y, Si Y, Kim JY, Chen ZF, Rao Y. Molecular regulation of sexual preference revealed by genetic studies of 5-HT in the brains of male mice. Nature. 2011;472:95-9.
41. Zhang S, Liu Y, Rao Y. Serotonin signaling in the brain of adult female mice is required for sexual preference. Proc Natl Acad Sci U S A. 2013;110:9968-73.
42. Wöhr M, Roullet FI, Hung AY, Sheng M, Crawley JN. Communication impairments in mice lacking Shank1: reduced levels of ultrasonic vocalizations and scent marking behavior. PLoS One. 2011;6:e20631.
43. Yang M, Bozdagi O, Scattoni ML, Wöhr M, Roullet FI, Katz AM, et al. Reduced excitatory neurotransmission and mild autism-relevant phenotypes in adolescent Shank3 null mutant mice. J Neurosci. 2012;32:6525-41.
44. Wöhr M, Dahlhoff M, Wolf E, Holsboer F, Schwarting RKW, Wotjak CT. Effects of genetic background, gender, and early environmental factors on isolation-induced ultrasonic calling in mouse pups: an embryo-transfer study. Behav Genet. 2008;38:579-95.
45. Cazalets JR, Gardette M, Hilaire G. Locomotor network maturation is transiently delayed in the MAOA-deficient mouse. J Neurophysiol. 2000;83:2468-70.
46. Ristine LA, Spear LP. Effects of serotonergic and cholinergic antagonists on suckling behavior of neonatal, infant, and weanling rat pups. Behav Neural Biol. 1984;41:99-126.
47. Hung AY, Futai K, Sala C, Valtschanoff JG, Ryu J, Woodworth MA, et al. Smaller dendritic spines, weaker synaptic transmission, but enhanced spatial learning in mice lacking Shank1. J Neurosci. 2008;28:1697-708.
48. Silverman JL, Turner SM, Barkan CL, Tolu SS, Saxena R, Hung AY, et al. Sociability and motor functions in Shank1 mutant mice. Brain Res. 2011;1380:120-37.
49. Sungur AÖ, Vörckel KJ, Schwarting RKW, Wöhr M. Repetitive behaviors in the Shank1 knockout mouse model for autism spectrum disorder: developmental aspects and effects of social context. J Neurosci Methods. 2014;234:92-100.
50. Ey E, Torquet N, Le Sourd AM, Leblond CS, Boeckers TM, Faure P, et al. The Autism ProSAP1/Shank2 mouse model displays quantitative and structural abnormalities in ultrasonic vocalisations. Behav Brain Res. 2013;256:677-89.
51. Hahn ME, Hewitt JK, Schanz N, Weinreb L, Henry A. Genetic and developmental influences on infant mouse ultrasonic calling. I. A diallel analysis of the calls of 3-day olds. Behav Genet. 1997;27:133-43.
52. Hahn ME, Benno RH, Schanz N, Phadia E. The effects of prenatal cocaine exposure and genotype on the ultrasonic calls of infant mice. Pharmacol Biochem Behav. 2000;67:729-38.
53. Hahn ME, Schanz N. The effects of cold, rotation, and genotype on the production of ultrasonic calls in infant mice. Behav Genet. 2002;32:267-73.
54. Roubertoux PL, Martin B, LeRoy I, Beau J, Marchaland C, Perez-Diaz F, et al. Vocalizations in newborn mice: genetic analysis. Behav Genet. 1996;26:427-37.
55. Hahn ME, Karkowski L, Weinreb L, Henry A, Schanz N. Genetic and developmental influences on infant mouse ultrasonic calling. II. Developmental patterns in the calls of mice 2-12 days of age. Behav Genet. 1998;28:315-25.
56. Kurz A, Wöhr M, Walter M, Bonin M, Auburger G, Gispert S, et al. Alpha-synuclein deficiency affects brain Foxp1 expression and ultrasonic vocalization. Neuroscience. 2010;17:287-98.
57. Hofer MA, Shair HN. Ultrasonic vocalization, laryngeal braking, and thermogenesis in rat pups: a reappraisal. Behav Neurosci. 1993;107:354-62.
58. Cummings KJ, Li A, Nattie EE. Brainstem serotonin deficiency in the neonatal period: autonomic dysregulation during mild cold stress. J Physiol. 2011;589:2055-64.
59. Ehret G. Left hemisphere advantage in the mouse brain for recognizing ultrasonic communication calls. Nature. 1987;325:249-51.
60. Ehret G. Categorical perception of mouse-pup ultrasounds in the temporal domain. Anim Behav. 1992;43:409-16.
61. Ehret G, Haack B. Ultrasound recognition in house mice: key-stimulus configuration and recognition mechanisms. J Comp Physiol. 1982;148:245-51.
62. Sewell GD. Ultrasonic communication in rodents. Nature. 1970;227:410.
63. Smith JC. Responses to adult mice to models infant calls. J Comp Physiol Psychol. 1976;90:1105-15.
64. Benton D, Nastiti K. The influence of psychotropic drugs on the ultrasonic calling of mouse pups. Psychopharmacology (Berl). 1988;95:99-102.
65. Gardner CR. Distress vocalization in rat pups. A simple screening method for anxiolytic drugs. J Pharmacol Methods. 1985;14:181-7.
66. Kehne JH, McCloskey TC, Baron BM, Chi EM, Harrison BL, Whitten JP, et al. NMDA receptor complex antagonists have potential anxiolytic effects as measured with separation-induced ultrasonic vocalizations. Eur J Pharmacol. 1991;193:283-92.
67. Podhorna J, Brown RE. Flibanserin has anxiolytic effects without locomotor side effects in the infant rat ultrasonic vocalization model of anxiety. Br J Pharmacol. 2000;130:739-46.
68. Brunner D, Buhot MC, Hen R, Hofer M. Anxiety, motor activation, and maternal-infant interactions in 5HT1B knockout mice. Behav Neurosci. 1999;113:587-601.
69. El-Khodor BF, Dimmler MH, Amara DA, Hofer M, Hen R, Brunner D. Juvenile 5HT(1B) receptor knockout mice exhibit reduced pharmacological sensitivity to 5HT(1A) receptor activation. Int J Dev Neurosci. 2004;22:405-13.
70. van Velzen A, Toth M. Role of maternal 5-HT(1A) receptor in programming offspring emotional and physical development. Genes Brain Behav. 2010;9:877-85.
71. Weller A, Leguisamo AC, Towns L, Ramboz S, Bagiella E, Hofer M, et al. Maternal effects in infant and adult phenotypes of 5HT1A and 5HT1B receptor knockout mice. Dev Psychobiol. 2003;42:194-205.
72. Zanettini C, Carola V, Lo Iacono L, Moles A, Gross C, D'Amato FR. Postnatal handling reverses social anxiety in serotonin receptor 1A knockout mice. Genes Brain Behav. 2010;9:26-32.
73. Brunelli SA, Aviles JA, Gannon KS, Branscomb A, Shacham S. PRX-00023, a selective serotonin 1A receptor agonist, reduces ultrasonic vocalizations in infant rats bred for high infantile anxiety. Pharmacol Biochem Behav. 2009;94:8-15.
74. Chugani DC, Muzik O, Behen M, Rothermel R, Janisse JJ, Lee J, et al. Developmental changes in brain serotonin synthesis capacity in autistic and nonautistic children. Ann Neurol. 1999;45:287-95.
75. Chugani DC, Muzik O, Rothermel R, Behen M, Chakraborty P, Mangner T, et al. Altered serotonin synthesis in the dentatothalamocortical pathway in autistic boys. Ann Neurol. 1997;42:666-9.
76. Chandana SR, Behen ME, Juhász C, Muzik O, Rothermel RD, Mangner TJ, et al. Significance of abnormalities in developmental trajectory and asymmetry of cortical serotonin synthesis in autism. Int J Dev Neurosci. 2005;23:171-82.
77. Makkonen I, Riikonen R, Kokki H, Airaksinen MM, Kuikka JT. Serotonin and dopamine transporter binding in children with autism determined by SPECT. Dev Med Child Neurol. 2008;50:593-7.
78. Coon H, Dunn D, Lainhart J, Miller J, Hamil C, Battaglia A, et al. Possible association between autism and variants in the brain-expressed tryptophan hydroxylase gene (TPH2). Am J Med Genet B Neuropsychiatr Genet. 2005;135B:42-6.
79. Voineagu I, Wang X, Johnston P, Lowe JK, Tian Y, Horvath S, et al. Transcriptomic analysis of autistic brain reveals convergent molecular pathology. Nature. 2011;474:380-4.
80. Yang SY, Yoo HJ, Cho IH, Park M, Kim SA. Association with tryptophan hydroxylase 2 gene polymorphisms and autism spectrum disorders in Korean families. Neurosci Res. 2012;73:333-6.
81. Delorme R, Durand CM, Betancur C, Wagner M, Ruhrmann S, Grabe HJ, et al. No human tryptophan hydroxylase-2 gene R441H mutation in a large cohort of psychiatric patients and control subjects. Biol Psychiatry. 2006;60:202-3.
82. Egawa J, Watanabe Y, Nunokawa A, Endo T, Kaneko N, Tamura R, et al. A detailed association analysis between the tryptophan hydroxylase 2 (TPH2) gene and autism spectrum disorders in a Japanese population. Psychiatry Res. 2012;196:320-2.
83. Ramoz N, Cai G, Reichert JG, Corwin TE, Kryzak LA, Smith CJ, et al. Family-based association study of TPH1 and TPH2 polymorphisms in autism. Am J Med Genet B Neuropsychiatr Genet. 2006;141B:861-7.
84. Sacco R, Papaleo V, Hager J, Rousseau F, Moessner R, Militerni R, et al. Case-control and family-based association studies of candidate genes in autistic disorder and its endophenotypes: TPH2 and GLO1. BMC Med Genet. 2007;8:11.
85. Veenstra-VanderWeele J, Muller CL, Iwamoto H, Sauer JE, Owens WA, Shah CR, et al. Autism gene variant causes hyperserotonemia, serotonin receptor hypersensitivity, social impairment and repetitive behavior. Proc Natl Acad Sci U S A. 2012;109:5469-74.
86. Kerr TM, Muller CL, Miah M, Jetter CS, Pfeiffer R, Shah C, et al. Genetic background modulates phenotypes of serotonin transporter Ala56 knock-in mice. Mol Autism. 2013;4:35.
87. Jones KL, Smith RM, Edwards KS, Givens B, Tilley MR, Beversdorf DQ. Combined effect of maternal serotonin transporter genotype and prenatal stress in modulating offspring social interaction in mice. Int J Dev Neurosci. 2010;28:529-36.
88. Dougherty JD, Maloney SE, Wozniak DF, Rieger MA, Sonnenblick L, Coppola G, et al. The disruption of Celf6, a gene identified by translational profiling of serotonergic neurons, results in autism-related behaviors. J Neurosci. 2013;33:2732-53.
89. Nakatani J, Tamada K, Hatanaka F, Ise S, Ohta H, Inoue K, et al. Abnormal behavior in a chromosome-engineered mouse model for human 15q11-13 duplication seen in autism. Cell. 2009;137:1235-46.